The Kadota Fund International Forum 2004–Clinical group consensus*

References

• Seegenschmiedt MH, Vernon CC. A historical perspective on hyperthermia in oncology. Thermoradiotheraphy and thermochemotheraphy, Volume 1, MH Seegenschmiedt, P Fessenden, CC Vernon. Springer Verlag, Berlin 1995; 3–44
   Google Scholar
• Myerson RJ, Moros E, Roti Roti JL. Hyperthermia. Principles and practice of radiation oncology, Third, CA Perez, LW Brady. Lippincott-Raben Publishers, Philadelphia 1997; 637–683
   Google Scholar
• Coit DG. Hyperthermic isolation limb perfusion for malignant melanoma: A review. Cancer Investigation 1992; 10: 277–284
   PubMed Web of Science ®Google Scholar
• Ceelen WP, Hesse U, De Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surgery 2000; 87: 1006–1015
   PubMed Web of Science ®Google Scholar
• Robins HI. on behalf of SHOWG members. Meeting report. Systemic Hyperthermia Oncological Working Group. Oncology 1995; 52: 260–263
   PubMed Web of Science ®Google Scholar
• Robins HI, Dennis WH, Neville AJ, Shecterle LM, Martin PA, Grossman J, Davis TE, Neville SR, Gillis WK, Rusy BF. A nontoxic system for 41.8°C whole-body hyperthermia: Results of a phase I study using a radiant heat device. Cancer Research 1985; 45: 3937–3944
   PubMed Web of Science ®Google Scholar
• Bull JCM. Clinical practice of whole-body hyperthermia: New directions. Thermoradiotheraphy and thermochemotheraphy, MH Seegenschmiedt, P Fessenden, CC Vernon. Springer Verlag, Berlin 1995; 2: 303–322
   Google Scholar
• Hetzel FW, Mattiello J. Interactions of hyperthermia with other modalities. In: Paliwal BR, Hetzel FW, & Dewhirst MW, editors. Medical Physics Monograph. Biological, physical and clinical aspects of hyperthermia. Am Inst Phys 1987; 16: 30–56
   Google Scholar
• Manning MR, Cetas TC, Miller RC, Oleson JR, Connor WG, Gerner EW. Clinical hyperthermia: Results of a phase I trial employing hyperthermia alone or in combination with external beam or interstitial radiotherapy. Cancer 1982; 49: 05–216
   Web of Science ®Google Scholar
• Dunlop PRC, Hand JW, Dickinson RJ, Field SB. An assessment of local hyperthermia in clinical practice. Int J Hyperthermia 1986; 2: 39–50
   PubMedGoogle Scholar
• Gabriele P, Orecchia R, Ragona R, Tseroni V, Sannazzari GL. Hyperthermia alone in the treatment of recurrences of malignant tumors. Cancer 1990; 66: 191–2195
   Web of Science ®Google Scholar
• Van der Zee J, Treurniet-Donker AD, The SK, Helle PA, Wijnmaalen AJ, Van den Berg AP, Van Rhoon GC, Broekmeyer-Reurink MP, Reinhold HS. Low dose reirradiation in combination with hyperthermia: a palliative treatment for patients with breast cancer recurring in previously irradiated areas. Int J Radiat Oncol Biol Phys 1988; 15: 1407–1413
   PubMed Web of Science ®Google Scholar
• Valdagni R, Amichetti M, Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial. Int J Radiat Oncol Biol Phys 1988; 15: 13–24
   PubMed Web of Science ®Google Scholar
• Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1993; 28: 163–169
   Web of Science ®Google Scholar
• Overgaard J, González González D, Hulshof MCCM, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995; 345: 540–543
   PubMed Web of Science ®Google Scholar
• International Collaborative Hyperthermia Group: Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, Van der Zee J, Van Putten WLJ, Van Rhoon GC, Van Dijk JDP, González González D, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 1996; 35: 731–744
   PubMed Web of Science ®Google Scholar
• Sneed PK, Stauffer PR, McDermott W, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998; 40: 287–295
   PubMed Web of Science ®Google Scholar
• Van der Zee J, González González D, Van Rhoon GC, Van Dijk JDP, Van Putten WLJ, Hart AAM,. for the Dutch Deep Hyperthermia Group. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Lancet 2000; 355: 119–1125
   PubMed Web of Science ®Google Scholar
• Berdow BA. Menteshashvili., Thermoradiotherapy of patient with locally advanced carcinoma of the rectum. Int J Hyperthermia 1990; 6: 881–890
   PubMed Web of Science ®Google Scholar
• Datta NR, Bose AK, Kapoor HK. Thermoradiotherapy in the management of carcinoma cervix (stage IIIb): A controlled clinical study. Indian Med Gazette 1987; 121: 68–71
   Google Scholar
• Egawa S, Tsukiyama I, Watanabe S, Ohno Y, Morita K, Tominaga S, Onoyama Y, Hashimoto S, Yanagawa S, Uehara S, et al. A randomized clinical trial of hyperthermia and radiation versus radiation alone for superficially located cancers. J Jpn Soc Ther Radiol Oncol 1989; 1: 135–140
   Google Scholar
• Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIb cervical carcinoma. Int J Hyperthermia 2001; 17: 97–105
   PubMed Web of Science ®Google Scholar
• Kakehi M, Ueda K, Mukojima T, Hiraoka M, Seto O, Akanuma A, Nakatsugawa S. Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. Int J Hyperthermia 1990; 6: 719–740
   PubMed Web of Science ®Google Scholar
• Strotsky AV, Fradkin SZ, Zhavrid EA, Karpovich UA. Combined therapy of bladder cancer with the use of hyperthermia. Strahlenther Onkol 1991; 167: 346
   Google Scholar
• Wang J, Li D, Chen N. Intracavitary microwave hyperthermia combined with external irradiation in the treatment of esophageal cancer. Zhonghua Zhong Liu Za Zhi 1996; 18: 51–54
   PubMedGoogle Scholar
• You Q-S, Wang R-Z, Suen G-Q, Yan F-C, Gao Y-J, Cui S-R, Zhao J-H, Zhao T-Z, Ding L. Combination preoperative radiation and endocavitary hyperthermia for rectal cancer: Long-term results of 44 patients. Int J Hyperthermia 1993; 9: 19–24
   PubMed Web of Science ®Google Scholar
• Colombo R, Da Pozzo LF, Gev A, Freschi M, Gallus G, Rigatii P. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urology 1996; 155: 1227–1232
   PubMed Web of Science ®Google Scholar
• Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J, Caldarera E, Pavone-Macalusa M. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003; 21: 4270–4276
   PubMed Web of Science ®Google Scholar
• Engelhardt R, Neumann H, Müller U, Löhr GW. Clinical studies in whole body hyperthermia. Hyperthermic oncology, T Sugahara, M Saito. Taylor and Francis, London 1989; 2: 509–510
   Google Scholar
• Issels RD, Lindner LH, Wust P, Hohenberger P, Jauch K, Daugaard S, Mansmann U, Hiddemann W, Blay J, Verweij J. Regional hyperthermia (RHT)improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: A phase III randomized pros. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25(18S)10009
   Google Scholar
• Kitamura K, Kuwano H, Watanabe M, Nozoe T, Yasuda M, Dumiyoshi K, Saku M, Sugimacahi K. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 1995; 60: 55–58
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Kitamura K, Baba K, Ikebe M, Morita M, Matsuda H, Kuwano H. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus: A prospective randomized trial. Int J Hyperthermia 1992; 8: 289–295
   PubMed Web of Science ®Google Scholar
• Van der Zee J. Heating the patient: A promising approach? Ann Oncol 2002; 13: 1173–1184
   Google Scholar
• Vasanthan A, Mitsumori M, Park JH, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P, Tatsuzaki H, Tanaka Y, Hiraoka M. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2005; 61: 145–153
   PubMed Web of Science ®Google Scholar
• Datta NR, Bose AK, Kapoor HK, Gupta S. Head and neck cancers: Results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990; 6: 479–486
   PubMed Web of Science ®Google Scholar
• Marmor JB, Hahn GM. Combined radiation and hyperthermia in superficial human tumors. Cancer 1980; 46: 1986–1991
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial. Int J Hyperthermia 1994; 4: 485–493
   Google Scholar
• Sharma S, Patel FD, Sandhu APS, Gupta BD, Yadav NS. A prospective randomized trial of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether Hyperthermia Oncol 1989; 5: 151–159
   Google Scholar
• Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 1989; 16: 535–549
   PubMed Web of Science ®Google Scholar
• Shchepotin IB, Evans SRT, Chorny V, Osinsky S, Buras RR, Maligonov P, Shabahang M, Nauta RJ. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surg Oncol 1994; 3: 37–44
   PubMed Web of Science ®Google Scholar
• Perez CA, Gillespie B, Pajak T, Hornback NB, Emami B, Rubin P. Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: A report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1989; 16: 551–558
   PubMed Web of Science ®Google Scholar
• Perez CA, Pajak T, Emami B, Hornback NB, Tupchong L, Rubin P. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Am J Clin Oncol (CCT) 1991; 14(2)133–141
   PubMed Web of Science ®Google Scholar
• Emami B, Scott C, Perez CA, Asbell S, Swift P, Grigsby P, Montesano A, Rubin P, Curran W, Delrowe J, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively controlled randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1996; 34: 1097–1104
   PubMed Web of Science ®Google Scholar
• De Graaf-Strukowska L, van der Zee J, van Putten WLJ, Senan S. Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura–A single institution experience with 189 patients. Int J Radiat Oncol Biol Phys 1999; 43: 511–516
   PubMed Web of Science ®Google Scholar
• Wessalowski R, Kruck H, Pape H, Kahn T, Willers R, Göbel U. Hyperthermia for the treatment of patients with malignant germ cell tumors. A phase I/II study in ten children and adolescents with recurrent or refractory tumors. Cancer 1998; 82: 793–800
   PubMed Web of Science ®Google Scholar
• Wessalowski R, Schneider D, Mils O, Calaminus G, Engelbrecht V, Pape H, Engert J, Harms D, Göbel U. An approach for cure: Regional deep hyperthermia and PEI-chemotherapy in children and adolescents with unresectable malignant tumors. Presented at the 21th Annual Meeting of the European Society for Hyperthermic Oncology 2003
   Google Scholar
• Rietbroek RC, Schilthuis MS, Bakker PJM, Van Dijk JDP, Postma AJ, González González D, Bakker AJ, Van der Velden J, Helmerhorst TJM, Veenhof CHN. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 1997; 79: 935–943
   PubMed Web of Science ®Google Scholar
• De Wit R, Van der Zee J, Van der Burg MEL, Kruit WH, Logmans A, Van Rhoon GC, Verweij J. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer 1999; 80: 1387–1391
   PubMed Web of Science ®Google Scholar
• Jo S, Sugahara T, Yamamoto T. Clinical response of hyperthermia using heating equipment Thermotron-RF8 in Japan. Biomed Eng Appl Basis Comm 1994; 6: 340–362
   Google Scholar
• Kouloulias V, Plataniotis G, Kouvaris J, Dardoufas C, Gennatas C, Uzunoglu N, Papavasiliou C, Vlahos L. Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer. Feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol 2005; 28: 91–99
   PubMed Web of Science ®Google Scholar
• Van der Zee J, Van Rhoon GC, Wust P. In regard to Dr Vasanthan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153). Int J Radiat Oncol Biol Phys 2005; 62: 940–941
   Google Scholar
• Jones EL, Prosnitz LR, Dewhirst MW, Vujaskovic Z, Samulski TV, Oleson JR, Yu D, Myerson RJ, Moros EG, Hurwitz MD, et al. In regard to Vasanthan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153). Int J Radiat Oncol Biol Phys 2005; 63: 644
   Google Scholar
• Van der Zee J, Van der Holt B, Rietveld PJM, Helle PA, Wijnmaalen AJ, Van Putten WLJ, Van Rhoon GC. Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer 1999; 79: 483–490
   PubMed Web of Science ®Google Scholar
• Lee HK, Antell AG, Perez CA, Straube WL, Ramachandran G, Myerson RJ, Emami B, Molmenti EP, Buckner A, Lockett MA. Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: Prognostic factors in 196 tumors. Int J Radiat Oncol Biol Phys 1998; 40: 365–375
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23: 3079–3085
   PubMed Web of Science ®Google Scholar
• Fajardo LF. Pathological effects of hyperthermia in normal tissues. Cancer Research 1984; 44: 4826s–4835s
   PubMed Web of Science ®Google Scholar
• Haveman J, Sminia P, Wondergem J, Van der Zee J, Hulshof MCCM. Effects of hyperthermia on the central nervous system: What was learnt from animal studies? Int J Hyperthermia 2005; 21: 185–192
   PubMed Web of Science ®Google Scholar
• Haveman J, Van der Zee J, Wondergem J, Hoogeveen JF, Hulshof MCCM. Effects of hyperthermia on the peripheral nervous system: A review. Int J Hyperthermia 2004; 20: 371–391
   PubMed Web of Science ®Google Scholar
• Hume SP, Marigold JC, Michalowski A. The effect of local hyperthermia on non-proliferative, compared with proliferative, epithelial cells of the mouse intestinal mucosa. Radiation Research 1983; 94: 252–262
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Jo S, Akuta K, Nishimura Y, Takahashi M, Abe M. Radiofrequency capacitive hyperthermia for deep-seated tumors II. Effect of thermoradiotherapy. Cancer 1987; 60: 128–135
   PubMed Web of Science ®Google Scholar
• Lee CK, Song CW, Rhee JG, Foy JA, Levitt SH. Clinical experience using 8 MHz radiofrequency capacitive hyperthermia in combination with radiotherapy: Results of a phase I/II study. Int J Radiat Oncol Biol Phys 1995; 32: 733–745
   PubMed Web of Science ®Google Scholar
• Petrovich Z, Langholz B, Gibbs FA, Sapozink MD, Kapp DS, Stewart RJ, Emami B, Oleson J, Senzer N, Slater J, et al. Regional hyperthermia for advanced tumors: A clinical study of 353 patients. Int J Radiat Oncol Biol Phys 1989; 16: 601–607
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Kato F, Yahara K, Morioka T, Nakano K, Korogi Y. Radiotherapy with 8 MHz radiofrequency-capacitive regional hyperthermia for pain relief of unresectable and recurrent colorectal cancer. Int J Hyperthermia 2006; 22: 1–14
   PubMed Web of Science ®Google Scholar
• Cavaliere R, Di Filippo F, Cavaliere F, Carlini S, Schiratti M, Anzà M, Garinei R, Callopoli A, Capua A, Impiombato FA, . Clinical practice of hyperthermic extremity perfusion in combination with radiotherapy and chemotherapy. Thermoradiotherapy and thermochemotherapy, MH Seegenschmiedt, P Fessenden, CC Vernon, et al. Springer Verlag, Berlin 1996; 2: 323–345
   Google Scholar
• Van der Zee J, González González D. The Dutch Deep Hyperthermia Trial: Results in cervical cancer. Int J Hyperthermia 2002; 18: 1–12
   PubMed Web of Science ®Google Scholar
• Wust P, Fahling H, Helzel T, Kniephoff M, Wlodarczyk W, Monich G, Felix R. Design and test of a new multi-amplifier system with phase and amplitude control. Int J Hyperthermia 1998; 14: 459–477
   PubMed Web of Science ®Google Scholar
• Van Rhoon GC, Rietveld PCM, Van der Zee J. A 433 MHz Lucite Cone waveguide applicator for superficial hyperthermia. Int J Hyperthermia 1998; 14: 13–27
   PubMed Web of Science ®Google Scholar
• Rietveld PJM, Van Putten WLJ, Van der Zee J, Van Rhoon GC. Comparison of the clinical effectiveness of the 433 MHz Lucite Cone applicator with that of a conventional waveguide applicator in applications of superficial hyperthermia. Int J Radiat Oncol Biol Phys 1999; 43: 681–687
   PubMed Web of Science ®Google Scholar
• Wust P, Seebass M, Nadobny J, Deuflhard P, Monich G, Felix R. Simulation studies promote technological development of radiofrequency phased array hyperthermia. Int J Hyperthermia 1996; 12: 477–494
   PubMed Web of Science ®Google Scholar
• Lagendijk JJW. Hyperthermia treatment planning. Phys Med Biol 2000; 45: R61–R76
   PubMed Web of Science ®Google Scholar
• Gellermann J, Wust P, Stalling D, Seebass M, Nadobny J, Beck R, Hege H-C, Deuflhard P, Felix R. Clinical evaluation and verification of the hyperthermia treatment planning system Hyperplan. Int J Radiat Oncol Biol Phys 2000; 47: 1145–1156
   PubMed Web of Science ®Google Scholar
• Carter DL, MacFall JR, Clegg ST, Wan X, Prescott DM, Charles HC, Samulski TV. Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma. Int J Radiat Oncol Biol Phys 1998; 40: 815–822
   PubMed Web of Science ®Google Scholar
• Hentschel M, Dreher W, Wust P, Roll S, Leibfritz D, Felix R. Fast spectroscopic imaging for non-invasive thermometry using the Pr[MOE-DO3A] complex. Phys Med Biol 1999; 44: 2397–2408
   PubMed Web of Science ®Google Scholar
• Gellermann J, Wlodarczyk W, Hildebrandt B, Ganter H, Nicolau A, Rau B, Tilly W, Fähling H, Nadobny J, Felix R, et al. Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res 2005; 65: 5872–5880
   PubMed Web of Science ®Google Scholar
• Yatvin MB, Mühlensiepen H, Porschen W, Weinstein JN, Feinendegen LE. Selective delivery of liposome-associated cis-Dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth. Cancer Res 1981; 41: 1602–1607
   PubMed Web of Science ®Google Scholar
• Matteucci ML, Anyarambhatla G, Rosner G, Azuma C, Fisher PA, Dewhirst MW, Needham D, Thrall DE. Hyperthermia increases accumulation of Technetium-99M-labeled liposomes in feline sarcomas. Clin Cancer Res 2000; 6: 3748–3755
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000; 60: 6950–6957
   PubMed Web of Science ®Google Scholar
• Multhoff G, Botzler C, Wiesnet M, Müller E, Meier T, Wilmanns W, Issels RD. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 1995; 61: 272–279
   PubMed Web of Science ®Google Scholar
• Multhoff G, Botzler C, Wiesnet M, Eissner G, Issels R. CD-3 large granular lymhocytes recognize a heat-inducible immunogenic determinant associated with the 72-kD heat shock protein on human sarcoma cells. Blood 1995; 86: 1374–1384
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000; 12: 1539–1546
   PubMed Web of Science ®Google Scholar
• Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 2001; 50: 515–522
   PubMed Web of Science ®Google Scholar
• Gerner EW, Hersh EM, Pennington M, Tsang TC, Harris D, Vasanwala F, Brailey J. Heat-inducible vectors for use in gene therapy. Int J Hyperthermia 2000; 16: 171–181
   PubMed Web of Science ®Google Scholar
• Huang Q, Hu JK, Lohr F, Zhang L, Braun R, Lanzen J, Little JB, Dewhirst MW, Li C-Y. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 2000; 60: 3435–3439
   PubMed Web of Science ®Google Scholar
• Okamota K, Shinoura N, Egawa N, Asai A, Kirino T, Shibasaki F, Shitara N. Adnovirus-mediated transfer of p53 augments hyperthermia-induced apoptosis in U251 glioma cells. Int J Radiat Oncol Biol Phys 2001; 50: 525–531
   PubMed Web of Science ®Google Scholar
• Lohr F, Hu K, Huang Q, Zhang L, Samulski TV, Dewhirst MW, Li C-Y. Enhancement of radiotherapy by hyperthermia-regulated gene therapy. Int J Radiat Oncol Biol Phys 2000; 48: 1513–1518
   PubMed Web of Science ®Google Scholar
• Benowitz S. Bone marrow experts are still debating the value of purging. J Nat Canc Inst 2000; 92: 190–192
   PubMedGoogle Scholar
• Moriyama Y, Narita M, Sato K, Urushiyama M, Koyama S, Hirosawa H, Kishi K, Takahashi M, Takai K, Shibata A. Application of hyperthermia to the treatment of human acute leukemia: Purging human leukemic progenitor cells by heat. Blood 1986; 67: 802–804
   PubMed Web of Science ®Google Scholar
• Iwasawa T, Hirabayashi Y, Kubota N, Inoue T, Kakehi M, Matsui K. Hyperthermic purging in vitro of murine leukemia cells (MK-8057): Surviving fractions of normal and leukemic stem cells and the long-term survival of mice injected with the post-hyperthermic leukemia cells. Exp Hematol 1991; 19: 332–337
   PubMed Web of Science ®Google Scholar
• Osman Y, Moriyama Y, Shibata A. Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-alpha, TNF, and quercetin): Its application to autologous bone marrow transplantation for CML. Exp Hematol 1995; 23: 444–452
   Google Scholar
• Wierenga PK, Setroikromo R, Vellenga E, Kampinga HH. Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: Enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3). Br J Haematol 2000; 111: 1145–1152
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Lee SH, Rood KL, Stewart MJ, Lyons JC, Lew YS, Park H, Song CW. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors. Neoplasia 2000; 2: 555–560
   PubMed Web of Science ®Google Scholar
• Horsman MR, Murata R, Overgaard J. Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation. Acta Oncol 2001; 40: 497–503
   PubMed Web of Science ®Google Scholar
• Eikesdal HP, Bjerkvig R, Dahl O. Vinblastine and hyperthermia target the neovasculature in BT4AN rat gliomas: Therapeutic implications of the vascular phenotype. Int J Radiat Oncol Biol Phys 2001; 51: 535–544
   PubMed Web of Science ®Google Scholar
• Eikesdal HP, Bjerkvig R, Mella O, Dahl O. Combrestatin A-4 and hyperthermia: A potent combination for the treatment of solid tumors. Radiother Oncol 2001; 60: 147–154
   PubMed Web of Science ®Google Scholar